These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7947304)

  • 1. Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
    Neuwelt EA; Wiliams PC; Mickey BE; Frenkel EP; Henner WD
    Pediatr Neurosurg; 1994; 21(1):16-22. PubMed ID: 7947304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
    Sawamura Y; Shirato H; Ikeda J; Tada M; Ishii N; Kato T; Abe H; Fujieda K
    J Neurosurg; 1998 Jan; 88(1):66-72. PubMed ID: 9420074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking down barriers to treat a patient with a germinoma: a case study.
    Bell S
    J Neurosci Nurs; 2004 Aug; 36(4):195-9. PubMed ID: 15366544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
    Jensen AW; Laack NN; Buckner JC; Schomberg PJ; Wetmore CJ; Brown PD
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1449-56. PubMed ID: 20045266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    Pediatr Blood Cancer; 2004 Aug; 43(2):126-33. PubMed ID: 15236278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of 5 patients with intracranial germinoma initially treated by chemotherapy alone.
    Ueba T; Yamashita K; Fujisawa I; Nakao S; Ooyama K; Yorihuji T; Kato SF; Seto S; Kageyama N
    Acta Neurochir (Wien); 2007; 149(9):897-902; discussion 902. PubMed ID: 17690837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of primary central nervous system germinoma after dexamethasone administration: a case report.
    Si SJ; Khatua S; Dhall G; Nelson MD; Gonzalez-Gomez I; Finlay JL
    Pediatr Hematol Oncol; 2010 Apr; 27(3):237-43. PubMed ID: 20367268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrence of intracranial germinoma initially treated with chemotherapy only].
    Kumabe T; Kusaka Y; Jokura H; Ikeda H; Shirane R; Yoshimoto T
    No Shinkei Geka; 2002 Sep; 30(9):935-42. PubMed ID: 12233091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
    Merchant TE; Davis BJ; Sheldon JM; Leibel SA
    J Clin Oncol; 1998 Jan; 16(1):204-9. PubMed ID: 9440744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.
    Scherz A; Feller K; Berezowska S; Genitsch V; Zweifel M
    Anticancer Res; 2017 Jun; 37(6):3111-3115. PubMed ID: 28551652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
    Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
    J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor.
    Aharinejad S; Fink M; Abri H; Nedwed S; Schlag MG; Macfelda K; Abraham D; Miksovsky A; Höltl E; Höltl W
    J Urol; 2002 Jan; 167(1):368-74. PubMed ID: 11743358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.
    Fortin D; McAllister LD; Nesbit G; Doolittle ND; Miner M; Hanson EJ; Neuwelt EA
    AJNR Am J Neuroradiol; 1999; 20(10):1794-802. PubMed ID: 10588099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of central nervous system germinoma treatment by chemoradiation.
    Tseng CK; Tsang NM; Jaing TH; Liau CT; Wu CT; Lin KL
    J Pediatr Hematol Oncol; 2011 May; 33(4):e138-42. PubMed ID: 21516012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.